title: The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design.
abstract: BACKGROUND
  The Lung Cancer Exercise Training Study (LUNGEVITY) is a randomized trial to investigate the efficacy of different types of exercise training on cardiorespiratory fitness (VO2peak), patient-reported outcomes, and the organ components that govern VO2peak in post-operative non-small cell lung cancer (NSCLC) patients.
  
  
  METHODS
  Using a single-center, randomized design, 160 subjects (40 patients/study arm) with histologically confirmed stage I-IIIA NSCLC following curative-intent complete surgical resection at Duke University Medical Center (DUMC) will be potentially eligible for this trial. Following baseline assessments, eligible participants will be randomly assigned to one of four conditions: (1) aerobic training alone, (2) resistance training alone, (3) the combination of aerobic and resistance training, or (4) attention-control (progressive stretching). The ultimate goal for all exercise training groups will be 3 supervised exercise sessions per week an intensity above 70% of the individually determined VO2peak for aerobic training and an intensity between 60 and 80% of one-repetition maximum for resistance training, for 30-45 minutes/session. Progressive stretching will be matched to the exercise groups in terms of program length (i.e., 16 weeks), social interaction (participants will receive one-on-one instruction), and duration (30-45 mins/session). The primary study endpoint is VO2peak. Secondary endpoints include: patient-reported outcomes (PROs) (e.g., quality of life, fatigue, depression, etc.) and organ components of the oxygen cascade (i.e., pulmonary function, cardiac function, skeletal muscle function). All endpoints will be assessed at baseline and postintervention (16 weeks). Substudies will include genetic studies regarding individual responses to an exercise stimulus, theoretical determinants of exercise adherence, examination of the psychological mediators of the exercise - PRO relationship, and exercise-induced changes in gene expression.
  
  
  CONCLUSIONS
  VO2peak is becoming increasingly recognized as an outcome of major importance in NSCLC. LUNGEVITY will identify the optimal form of exercise training for NSCLC survivors as well as provide insight into the physiological mechanisms underlying this effect. Overall, this study will contribute to the establishment of clinical exercise therapy rehabilitation guidelines for patients across the entire NSCLC continuum.
  
  
  BACKGROUND
  NCT00018255.
authors.affiliation: Duke University Medical Center, Durham, NC, USA. jones442@mc.duke.edu
authors.forename: Lee W
authors.initials: LW
authors.lastname: Jones
authors.forename: Neil D
authors.initials: ND
authors.lastname: Eves
authors.forename: William E
authors.initials: WE
authors.lastname: Kraus
authors.forename: Anil
authors.initials: A
authors.lastname: Potti
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Crawford
authors.forename: James A
authors.initials: JA
authors.lastname: Blumenthal
authors.forename: Bercedis L
authors.initials: BL
authors.lastname: Peterson
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Douglas
mesh_terms: D000328:Adult; D000332:Aerobiosis; D002289:Carcinoma, Non-Small-Cell Lung / Q000503:physiopathology / Q000534:rehabilitation / Q000601:surgery / Q000628:therapy*; D023381:Endpoint Determination; D015444:Exercise / Q000502:physiology; D005081:Exercise Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000503:physiopathology / Q000534:rehabilitation / Q000601:surgery / Q000628:therapy*; D008297:Male; D010101:Oxygen Consumption / Q000502:physiology; D010349:Patient Compliance; D055070:Resistance Training / Q000379:methods
references.citation: Cancer. 2007 Dec 1;110(11):2511-8
references.pmid: 17955504
references.citation: J Appl Physiol (1985). 2008 Apr;104(4):1069-79
references.pmid: 18258800
references.citation: J Clin Oncol. 2008 Feb 20;26(6):907-12
references.pmid: 18281663
references.citation: Respir Med. 2007 Nov;101(11):2336-42
references.pmid: 17686622
references.citation: Methods Mol Biol. 2009;472:169-89
references.pmid: 19107433
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):87-95
references.pmid: 19124485
references.citation: J Clin Oncol. 2007 Jun 10;25(17):2345-51
references.pmid: 17557947
references.citation: Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1565-72
references.pmid: 14684375
references.citation: Circulation. 2000 Feb 22;101(7):828-33
references.pmid: 10683360
references.citation: Respirology. 2006 Nov;11(6):681-6
references.pmid: 17052294
references.citation: Thorax. 2006 Jan;61(1):57-60
references.pmid: 16244091
references.citation: J Clin Oncol. 2007 Jun 10;25(17):2335-7
references.pmid: 17557943
references.citation: Can J Cardiol. 2005 Dec;21(14):1277-80
references.pmid: 16341296
references.citation: Breast J. 2009 Jan-Feb;15(1):45-51
references.pmid: 19120381
references.citation: J Am Coll Cardiol. 2002 Apr 3;39(7):1170-4
references.pmid: 11923042
references.citation: Cancer. 2007 Aug 1;110(3):590-8
references.pmid: 17582629
references.citation: Ann Intern Med. 2008 Feb 19;148(4):295-309
references.pmid: 18283207
references.citation: Br J Cancer. 2000 Feb;82(4):800-5
references.pmid: 10732749
references.citation: Am J Surg. 2006 Nov;192(5):565-71
references.pmid: 17071185
references.citation: Oncol Nurs Forum. 2006 Sep 01;33(5):937-47; quiz 948-50
references.pmid: 16955122
references.citation: Psychooncology. 2009 Feb;18(2):128-33
references.pmid: 18536022
references.citation: J Clin Oncol. 2008 Aug 20;26(24):3958-64
references.pmid: 18711185
references.citation: CMAJ. 1999 May 4;160(9 Suppl):S29-34
references.pmid: 10333851
references.citation: Am J Phys Med Rehabil. 2002 Nov;81(11 Suppl):S3-16
references.pmid: 12409807
references.citation: Ann Surg Oncol. 2009 Jan;16(1):106-12
references.pmid: 18953612
references.citation: Chest. 2003 Jan;123(1 Suppl):105S-114S
references.pmid: 12527570
references.citation: J Clin Oncol. 2005 Feb 1;23(4):899-909
references.pmid: 15681536
references.citation: J Cancer Surviv. 2007 Jun;1(2):116-28
references.pmid: 18648952
references.citation: J Appl Physiol (1985). 1994 Aug;77(2):998-1005
references.pmid: 8002557
references.citation: Circulation. 1979 Sep;60(3):547-55
references.pmid: 455617
references.citation: J Gerontol A Biol Sci Med Sci. 2000 Jul;55(7):B336-46
references.pmid: 10898247
references.citation: J Clin Oncol. 2008 Jan 10;26(2):233-41
references.pmid: 18086802
references.citation: Eur J Appl Physiol. 2002 Nov;88(1-2):50-60
references.pmid: 12436270
references.citation: Cancer. 2008 Dec 15;113(12):3430-9
references.pmid: 18988290
references.citation: N Engl J Med. 2002 Mar 14;346(11):793-801
references.pmid: 11893790
references.citation: Chest. 2003 Jan;123(1 Suppl):97S-104S
references.pmid: 12527569
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):379-86
references.pmid: 18250341
references.citation: Lancet Oncol. 2006 Dec;7(12):1017-26
references.pmid: 17138223
references.citation: Pflugers Arch. 1997 Jan;433(3):238-44
references.pmid: 9064638
references.citation: Prog Cardiovasc Nurs. 2001 Fall;16(4):142-51
references.pmid: 11684905
references.citation: JAMA. 2005 May 25;293(20):2479-86
references.pmid: 15914748
references.citation: Curr Oncol. 2007 Oct;14(5):173-9
references.pmid: 17938700
references.citation: Clin Breast Cancer. 2008 Feb;8(1):70-9
references.pmid: 18501061
references.citation: Am J Epidemiol. 1988 Dec;128(6):1340-51
references.pmid: 3264110
references.citation: Lung Cancer. 1995 Jun;12(3):199-220
references.pmid: 7655830
references.citation: Lung Cancer. 2007 Feb;55(2):225-32
references.pmid: 17113185
references.citation: Lancet Oncol. 2008 Aug;9(8):757-65
references.pmid: 18672211
references.citation: J Appl Physiol (1985). 1997 Apr;82(4):1305-10
references.pmid: 9104869
references.citation: Thorac Surg Clin. 2004 Aug;14(3):353-65
references.pmid: 15382767
references.citation: Curr Oncol Rep. 2009 Jul;11(4):255-62
references.pmid: 19508829
references.citation: Annu Rev Psychol. 2001;52:27-58
references.pmid: 11148298
references.citation: Lung Cancer. 2007 Aug;57(2):175-80
references.pmid: 17442449
references.citation: Med Sci Sports Exerc. 1998 Jun;30(6):975-91
references.pmid: 9624661
references.citation: Clin Cardiol. 1979 Aug;2(4):257-63
references.pmid: 262574
references.citation: Lancet Oncol. 2009 Jun;10(6):598-605
references.pmid: 19482248
references.citation: Circulation. 2002 Aug 6;106(6):666-71
references.pmid: 12163425
references.citation: J Pain Symptom Manage. 2005 Aug;30(2):160-9
references.pmid: 16125031
references.citation: Respir Physiol. 1991 Jan;83(1):11-21
references.pmid: 2028103
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):306-13
references.pmid: 19124513
references.citation: CMAJ. 2006 Jul 4;175(1):34-41
references.pmid: 16818906
references.citation: Semin Hematol. 1997 Jul;34(3 Suppl 2):13-9
references.pmid: 9253779
references.citation: J Clin Invest. 1965 Sep;44:1514-22
references.pmid: 14332164
references.citation: Chest. 1993 Jul;104(1):155-9
references.pmid: 8325061
references.citation: BMJ. 1999 Apr 3;318(7188):901-4
references.pmid: 10102851